VEGFA and neoplasm: For instance, tamoxifen has also been shown to confer anti-angiogenic effects [54], partly through inhibition of protein kinase C [55, 56], and partly by diminishing the release of vascular endothelial growth factor from thrombocytes [57], and anti-metastatic effects, through prevention of platelet-assisted migration of tumor cells through the endothelium [57].